Next Article in Journal / Special Issue
Recent Advances in Chromatin Mechanisms Controlling Pancreatic Carcinogenesis
Previous Article in Journal
On the Relationships between LncRNAs and Other Orchestrating Regulators: Role of the Circadian System
Previous Article in Special Issue
Epigenetic Targeting of Aberrant Transcriptional Modulation in Pancreatic Cancer
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessReview

The Epigenetic Landscape of Pancreatic Cancer Stem Cells

Department of Surgery and Cancer, Division of Cancer, Imperial College London, Imperial Centre for Translational and Experimental Medicine (ICTEM), London W12 0NN, UK
Department of Biochemistry, Cancer Stem Cell and Tumor Microenvironment Group, Universidad Autónoma de Madrid (UAM), 28029 Madrid, Spain
Biomarkers and Therapeutic Targets Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Red de Investigación Renal (RedinRen) Instituto de Salud Carlos III (ISCIII), 28034 Madrid, Spain
Department of Cancer Biology, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 28029 Madrid, Spain
Chronic Diseases and Cancer Area, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain
Author to whom correspondence should be addressed.
Epigenomes 2018, 2(2), 10;
Received: 31 May 2018 / Revised: 8 June 2018 / Accepted: 11 June 2018 / Published: 14 June 2018
(This article belongs to the Special Issue Epigenetics of Pancreatic Cancer)
PDF [1250 KB, uploaded 14 June 2018]


Data now indicates that in addition to genetic alterations/mutations, human cancer cells exhibit important changes in their epigenome. In the context of this review, we define the epigenome as the chemical compounds and/or proteins that can interact with nuclear DNA to direct the specific and localized activation or silencing of genes to control the production of cellular proteins (directly or indirectly) in a given cell. Our ever-growing knowledge of how the epigenome can affect cellular processes has largely changed our view of cancer being a solely genetic disease. Nowadays, cancer is largely defined and characterized by the dynamic changes in both the genome and epigenome, which function together and contribute concomitantly to cancer initiation and progression. Since epigenetic modifications are crucial processes involved in controlling cellular identity and lineage fate, perturbations in this layer of gene regulation can contribute to the acquisition of new cellular characteristics different than those that were “initially” intended. For example, aberrant epigenetic alterations may transform normal non-cancer cells into cancer stem cells (CSCs), endowing them with the loss of differentiation and the acquisition of stem-like characteristics. In this review, we will focus our discussion on CSCs in the context of pancreatic ductal adenocarcinoma (PDAC). We will discuss how different epigenetic modifications create a landscape that can impact CSC identity and the way this small sub-population of cells contributes to tumor initiation, progression, and resistance to therapy. Moreover, we will highlight the latest discoveries in epigenetic-based therapies as a means of targeting CSCs. View Full-Text
Keywords: pancreatic cancer; cancer stem cells; plasticity; epigenetics; methylation; acetylation; non-coding RNA pancreatic cancer; cancer stem cells; plasticity; epigenetics; methylation; acetylation; non-coding RNA

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Zagorac, S.; Garcia-Bermejo, L.; Sainz, B., Jr. The Epigenetic Landscape of Pancreatic Cancer Stem Cells. Epigenomes 2018, 2, 10.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Epigenomes EISSN 2075-4655 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top